CN109069442A - 异甘草酸或其盐的吸入制剂及其在制备治疗呼吸系统疾病药物中的应用 - Google Patents

异甘草酸或其盐的吸入制剂及其在制备治疗呼吸系统疾病药物中的应用 Download PDF

Info

Publication number
CN109069442A
CN109069442A CN201780018629.0A CN201780018629A CN109069442A CN 109069442 A CN109069442 A CN 109069442A CN 201780018629 A CN201780018629 A CN 201780018629A CN 109069442 A CN109069442 A CN 109069442A
Authority
CN
China
Prior art keywords
preparation
sucking
lactose
magnesium isoglycyrrhetate
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201780018629.0A
Other languages
English (en)
Other versions
CN109069442B (zh
Inventor
顾红梅
王善春
张喜全
黄磊
徐宏江
宋伟
董平
孙中英
张颖
陈德洋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Original Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chia Tai Tianqing Pharmaceutical Group Co Ltd filed Critical Chia Tai Tianqing Pharmaceutical Group Co Ltd
Priority to CN202010842414.4A priority Critical patent/CN111920785B/zh
Publication of CN109069442A publication Critical patent/CN109069442A/zh
Application granted granted Critical
Publication of CN109069442B publication Critical patent/CN109069442B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本发明属于医药领域，涉及异甘草酸或其盐的吸入制剂，具体而言涉及异甘草酸镁的吸入制剂及其在制备治疗呼吸系统疾病药物中的应用。

Description

PCT国内申请，说明书已公开。

Claims (22)

  1. PCT国内申请，权利要求书已公开。
CN201780018629.0A 2016-04-15 2017-04-14 异甘草酸或其盐的吸入制剂及其应用 Active CN109069442B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010842414.4A CN111920785B (zh) 2016-04-15 2017-04-14 异甘草酸或其盐的吸入制剂及其应用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610237175 2016-04-15
CN2016102371753 2016-04-15
PCT/CN2017/080583 WO2017177966A1 (zh) 2016-04-15 2017-04-14 异甘草酸或其盐的吸入制剂及其在制备治疗呼吸系统疾病药物中的应用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202010842414.4A Division CN111920785B (zh) 2016-04-15 2017-04-14 异甘草酸或其盐的吸入制剂及其应用

Publications (2)

Publication Number Publication Date
CN109069442A true CN109069442A (zh) 2018-12-21
CN109069442B CN109069442B (zh) 2020-09-04

Family

ID=60042326

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202010842414.4A Active CN111920785B (zh) 2016-04-15 2017-04-14 异甘草酸或其盐的吸入制剂及其应用
CN201780018629.0A Active CN109069442B (zh) 2016-04-15 2017-04-14 异甘草酸或其盐的吸入制剂及其应用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN202010842414.4A Active CN111920785B (zh) 2016-04-15 2017-04-14 异甘草酸或其盐的吸入制剂及其应用

Country Status (12)

Country Link
US (2) US20190117568A1 (zh)
EP (1) EP3443954A4 (zh)
JP (2) JP7166929B2 (zh)
KR (1) KR102410183B1 (zh)
CN (2) CN111920785B (zh)
AU (1) AU2017251548B2 (zh)
BR (1) BR112018071208A2 (zh)
EA (1) EA201892350A1 (zh)
MX (1) MX2018012461A (zh)
PH (1) PH12018502195A1 (zh)
SG (2) SG11201809042SA (zh)
WO (1) WO2017177966A1 (zh)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101396368A (zh) * 2007-09-29 2009-04-01 江苏正大天晴药业股份有限公司 异甘草酸或其盐在治疗过敏性鼻炎中的应用
WO2012026928A1 (en) * 2010-08-25 2012-03-01 Diacarta Llc Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
WO2005004913A1 (ja) 2003-07-09 2005-01-20 Anges Mg, Inc. デコイを含む薬学的組成物およびその使用方法
WO2005004845A1 (en) 2003-07-11 2005-01-20 Glaxo Group Limited Pharmaceutical formulations comprising magnesium stearate
CN101023953B (zh) * 2006-07-24 2010-05-12 南开大学 治疗支气管哮喘的组合物
CN101190232B (zh) 2006-11-30 2011-08-17 江苏正大天晴药业股份有限公司 一种注射用异甘草酸镁冻干粉针剂及其制备方法
JP2008222682A (ja) * 2007-03-15 2008-09-25 Kumamoto Univ 線維化肺疾患治療薬、気道粘液分泌細胞過形成抑制剤および気道塞栓治療薬
CN101669962A (zh) * 2009-09-18 2010-03-17 杭州市第六人民医院 复合甘草酸氨基酸注射液及其制备方法和应用
CN103156930A (zh) 2011-12-19 2013-06-19 张亚军 一种含芍药和甘草提取物的呼吸道给药制剂
MY171125A (en) 2012-03-13 2019-09-26 Respivert Ltd Crystalline pi3 kinase inhibitors
CN102920936A (zh) * 2012-09-17 2013-02-13 陈泉生 一种治疗呼吸道疾病的吸盐物及其制作方法
CN104042573A (zh) * 2014-06-03 2014-09-17 青岛市市立医院 一种异甘草酸镁冻干粉针剂及其制备方法
CN106237297A (zh) * 2016-08-30 2016-12-21 吉林紫鑫药业股份有限公司 一种用于治疗慢性支气管炎的药物组合物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101396368A (zh) * 2007-09-29 2009-04-01 江苏正大天晴药业股份有限公司 异甘草酸或其盐在治疗过敏性鼻炎中的应用
WO2012026928A1 (en) * 2010-08-25 2012-03-01 Diacarta Llc Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
TZU-CHIEN KAO，ET AL: "Glycyrrhizic Acid and 18β-Glycyrrhetinic Acid Inhibit Inflammation via PI3K/Akt/GSK3β Signaling and Glucocorticoid Receptor Activation", 《J. AGRIC. FOOD CHEM.》 *
李艳丽，等: "异甘草酸镁注射液的临床应用", 《实用药物与临床》 *

Also Published As

Publication number Publication date
AU2017251548A1 (en) 2018-11-15
SG10202010192YA (en) 2020-11-27
CN111920785B (zh) 2022-05-20
MX2018012461A (es) 2019-09-18
US20200368158A1 (en) 2020-11-26
KR20180132143A (ko) 2018-12-11
CN109069442B (zh) 2020-09-04
EA201892350A1 (ru) 2019-06-28
JP2021176903A (ja) 2021-11-11
AU2017251548B2 (en) 2022-02-17
KR102410183B1 (ko) 2022-06-17
US20190117568A1 (en) 2019-04-25
SG11201809042SA (en) 2018-11-29
EP3443954A1 (en) 2019-02-20
WO2017177966A1 (zh) 2017-10-19
US11534398B2 (en) 2022-12-27
PH12018502195A1 (en) 2019-09-23
JP7309791B2 (ja) 2023-07-18
CN111920785A (zh) 2020-11-13
BR112018071208A2 (pt) 2019-02-12
JP7166929B2 (ja) 2022-11-08
EP3443954A4 (en) 2019-11-20
JP2019511556A (ja) 2019-04-25

Similar Documents

Publication Publication Date Title
CN107789340A (zh) 一种穿心莲雾化吸入用溶液制剂及其制备方法
TW200524615A (en) Aqueous suspensions of ciclesonide for nebulisation
CN103462942B (zh) 一种吸入用盐酸氨溴索溶液
AU2011307899A1 (en) Compound composition for inhalation used for treating asthma
CN109069442A (zh) 异甘草酸或其盐的吸入制剂及其在制备治疗呼吸系统疾病药物中的应用
CN104922620B (zh) 桑姜感冒注射液在制备雾化和直肠给药制剂中的应用及其制备方法
CN105456234A (zh) 一种新型抛射剂细辛脑吸入气雾剂及其制备方法
CN106420677A (zh) 一种具有抗肺癌活性的干粉吸入剂
CN102302475B (zh) 一种脂蟾毒配基干粉吸入剂及其制备方法、应用
CN115137713B (zh) 一种两性霉素b雾化吸入制剂及其制备方法
CN110522786A (zh) 一种吸入用紫花杜鹃溶液制剂及其制备方法
CN110522824A (zh) 一种吸入用牡荆油溶液制剂及其制备方法
CN102091062A (zh) 一种采取吸入给药紫杉醇治疗肺癌的方法
WO2022166724A1 (zh) 一种福多司坦吸入用溶液制剂及其制备方法和用途
JP2021176903A5 (zh)
CN107773593A (zh) 一种小儿清热止咳雾化吸入用溶液制剂及其制备方法
EA040563B1 (ru) Применение препарата для ингаляции на основе изоглицирризината магния для лечения заболеваний дыхательной системы
CN104523658B (zh) 一种厄多司坦吸入粉雾剂及其制备方法
CN117442588A (zh) 一种吸入用人干扰素α2b溶液及其制备方法
CN110522810A (zh) 一种吸入用小儿止咳溶液制剂及其制备方法
CN112121045A (zh) 肺炎患儿纤支镜手术用麻醉抗炎药物组合物和麻醉抗炎的方法
CN102225056A (zh) 含苦参碱的组合物在制备吸入式平喘药物的应用
CN102302476B (zh) 一种脱氢蟾蜍色胺干粉吸入剂及其制备方法、应用
JPWO2017177966A5 (zh)
CN107773688A (zh) 一种小儿清肺化痰雾化吸入用溶液制剂及其制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1261173

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant